Yulu Ao

3 days ago | scmp.com | Zhang Shidong |Yulu Ao

A blistering recovery in Hong Kong’s initial public offering (IPO) market this year has delivered a bonanza for investors, with returns above 30 per cent bucking a sluggish economy and languid property market. Holding new shares from the 34 companies that have pulled off offerings in 2025 would generate an average return of 34 per cent, according to Bloomberg data. Even selling the stocks upon their debuts would have fetched a 10 per cent gain, the data showed.

3 weeks ago | scmp.com | Yulu Ao |Cao Li

China’s equity markets are benefiting from a global shift away from US assets, though the outlook for the second half of 2025 is clouded by signs of a structural economic slowdown, persistent deflationary pressure and worries about an underwhelming policy stance from Beijing, according to strategists. In spite of elevated political and economic uncertainties, the probability of a global recession remained low, Natixis Investment Managers said on Tuesday.

1 month ago | scmp.com | Yulu Ao |Enoch Yiu

Hong Kong is taking another big step to strengthen financial-market linkages with the Middle East with the launch of Asia’s first exchange-traded fund (ETF) tracking Saudi Arabia’s Islamic government bonds, or sukuk. The ETF, called Premia BOCHK Saudi Arabia Government Sukuk ETF, started trading on the Hong Kong stock exchange on Thursday, giving local investors access to the world’s second-largest market for Shariah-compliant debt securities.

1 month ago | scmp.com | Yulu Ao |Aileen Chuang

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, began trading on the Hong Kong stock exchange on Friday, marking a key step in its international expansion and giving a boost to the city’s recovering initial public offerings (IPO) market. Trading under code 1276, Hengrui first changed hands at HK$57.00, up 29.4 per cent to its offer price of HK$44.05, in a stock offering that raised HK$9.89 billion (US$1.26 billion).

1 month ago | scmp.com | Zhang Shidong |Yulu Ao

The pricing of Contemporary Amperex Technology’s (CATL) Hong Kong shares at the top end of the range bodes well for China’s leading companies eyeing a listing in the city, but the richly valued offer price may hurt the new stock’s first-day performance due to its smaller-than-average discount to the company’s mainland-traded shares.